Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
MNCs Toasted by Import Substitution as China Launch New Program to Boost Domesti...
Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis on impacts of Chinese pharma industrial policies on MNC perf... (7/2/2018)
   
China's Biopharma Rise: Opportunities and Threats (7/10/2018)
BIO's China Summit Highlights Trends in BioPharma Market (7/6/2018)
Chinese Film Defending Smuggled Indian Anticancers Triggers Intensive and Emotional Debates (7/6/2018)
China Further Opens Market Access for Foreign Investors (7/3/2018)
China's State-Run Insurance Funds Feel Strain of Baby Boom (7/3/2018)
FT: Chinese Investment into US Biotech Start-ups Soars (7/3/2018)
MNCs Toasted by Import Substitution as China Launch New Program to Boost Domestic Pharma Outsourcing (7/2/2018)
Fresh Challenge for Chinese Investment in U.S. Biopharma (6/28/2018)
China's Removal of Imported Drug Tariffs: Implications for Foreign and Domestic Companies (6/21/2018)
China's Investors Pour Into Western Biotech Startups (6/15/2018)
China's Vaccine Tourists Drain Hong Kong's Supply of Cancer Drug (6/15/2018)
BMJ: Protecting the Accuracy of Clinical Trial Data in China (6/13/2018)
Hays: China's Middle Classes Are Growing in Numbers, Wealth and Influence over the Life Sciences Industry (6/12/2018)
Will China's Promise to Boost Imports Benefit MNC Pharma Companies? (6/10/2018)
The PD-1/PD-L1 Race in China (6/5/2018)
Bloomburg: Takeda Ups Its Bet on China  (7/18/2018)
Mesoblast Enters Into Strategic Cardiova...  (7/18/2018)
Medicines Containing Huahai's Valsartan ...  (7/17/2018)
Xinhua: China's New Drug for Alzheimer's...  (7/17/2018)
SAMR Solicits Comments on Draft GCP Revi...  (7/17/2018)
CDE Publicizes Batch 30 of Drug Applicat...  (7/17/2018)
State Council Revamps Healthcare Reform ...  (7/17/2018)
Ascentage Pharma Raises $150 Million in ...  (7/17/2018) (free)
China Embraces Another Vaccine Scandal  (7/17/2018)
Shanghai AIC Officially Terminates Antim...  (7/16/2018)
Healthcare Industry Associations Sign Ne...  (7/16/2018)
Recent Executive Moves  (7/13/2018)
CNDA Solicits Comments on GMP for Clinic...  (7/13/2018)
SMIA Mulls Tender for Anticancers as It ...  (7/13/2018)
NHC Reports on Growing Sector of Private...  (7/13/2018)
CANbridge Receives IND Approval to Commence CAN008 Phase...
Global Contract Pharmaceutical Manufacturing Market to R...
White House Task Force Echoes Pharma Proposals
Pharma Industry Reputation Rebounds Somewhat in 2016
Fresenius Steps Up Pharma M&A with Akorn, Merck KGaA...
IQVia: Overview of Urban Chinese Hospital Drug Sales in 2017
IQVia: Overview of Chinese Urban Retail Pharmacy Market in 2017...
Overview of Chinese Oncology Drug Market 2008-2018E
Chinese OTC Cough, Cold and Allergy Market Posted 6% Growth in ...
Data Snapshot: Chinese Generic Drug Market
Bloomburg: Takeda Ups Its Bet on China
Mesoblast Enters Into Strategic Cardiovascular Alliance for ...
Ascentage Pharma Raises $150 Million in Series C Financing
Merck and Xian Janssen to Co-launch Type 2 Diabetes Drug in ...
Ping An Reportedly to Make Rival Offer for China Biologic
SAMR Solicits Comments on Draft GCP Revision
CDE Publicizes Batch 30 of Drug Applications To Be Grant...
China Embraces Another Vaccine Scandal
CNDA Solicits Comments on GMP for Clinical Trial Drugs
CDE Solicits Comments on Technical Requirements for Topi...
Shanghai AIC Officially Terminates Antimonopoly Investigatio...
MSF Challenges Gilead's Chinese Patent HCV Drug Velpatasvir
U.S. Supreme Court Rules against Chinese Companies in Vitami...
MNC Pharma Cos Face Uncertainties of Chinese Data Transfer R...
SAMR Announces Major Initiative to Conduct Inspection over U...
Medicines Containing Huahai's Valsartan API Recalled in ...
EMA Reviewing and Recalling Medicines Containing Valsart...
U.S. FDA Warns Another Chinese API Maker for GMP Flaws
Bain Reportedly Near Deal to Acquire DSM Sinochem Pharma...
U.S. FDA Warns Henan Lihua Pharma over Data Integrity Is...
Xinhua: China's New Drug for Alzheimer's Completes Phase...
Sirona Biochem Announces CNDA Approval of SGLT2 Inhibito...
CStone's PD-1 Inhibitor CS1003 Gets Clinical Trial Appro...
China Close to Approve Fruquintinib for Colon Cancer
Luye Pharma's Class 1.1 New Analgesic to Start Phase I T...
State Council Revamps Healthcare Reform Leading Group
Healthcare Industry Associations Sign New Framework for ...
SMIA Mulls Tender for Anticancers as It Plans New Mechan...
NHC Reports on Growing Sector of Private Healthcare Prov...
Shanghai Unveils New Open Policy Measures, Benefiting Ph...
Recent Executive Moves
Recent Executive Moves
Recent Official and Executive Moves
Recent Executive Moves
Recent Official and Executive Moves
Upcoming Event: World Congress on Virology 2018
Upcoming Event: GUT Health Congress Asia 2018
Upcoming Event: 5th World Congress on Epigenetics and Ch...
Upcoming Event: 7th International Conference on Neurolog...
Upcoming Event: Shanghai eHealth Workshop
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Chi...
  WiCON and PharmaGuys Launch Ph...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Its...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links